Department of Cardiovascular Surgery, Diyarbakir Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Department of Perfusion, Diyarbakir Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Braz J Cardiovasc Surg. 2022 Dec 1;37(6):793-800. doi: 10.21470/1678-9741-2020-0422.
Del Nido cardioplegia was reported to provide adequate myocardial protection and clinical outcomes with improved surgical flow in adult cardiac surgical procedures. And many clinicians have already modified the traditional formula. This study aims to investigate the efficacy and safety of tepid modified del Nido cardioplegia compared to cold blood cardioplegia in adult patients undergoing cardiac surgery.
This retrospective study included one hundred consecutive adult patients undergoing cardiac surgical procedures using tepid modified del Nido cardioplegia. One hundred consecutive adult patients undergoing cardiac surgical procedures with cold blood cardioplegia were the control group. Propensity score matching yielded 89 modified del Nido and 89 cold blood cardioplegia patients.
There were no significant differences when comparing the two matched groups regarding the requirement for intraoperative defibrillation (P=0.36), postoperative peak troponin T levels (0.18), perioperative inotropic support (P=0.26), intra-aortic balloon pump requirement (P=0.62), and postoperative left ventricular ejection fraction at discharge (P=0.4) and on the sixth postoperative month (P=0.37). Mean cross-clamping time (P=0.005), cardiopulmonary bypass time (P=0.03), and total operation time (P=0.03) were significantly shorter in the del Nido group.
Tepid modified del Nido cardioplegia may be a safe alternative to cold blood cardioplegia in adult patients undergoing cardiac surgical procedures.
Del Nido 心脏停搏液被报道可在成人心脏手术中提供充分的心肌保护和改善手术流程的临床结果。并且许多临床医生已经对传统配方进行了修改。本研究旨在调查与冷血心脏停搏液相比,温热改良 Del Nido 心脏停搏液在成人心脏手术中的疗效和安全性。
本回顾性研究纳入了 100 例接受温热改良 Del Nido 心脏停搏液心脏手术的成年患者。100 例接受冷血心脏停搏液心脏手术的成年患者作为对照组。采用倾向评分匹配,得到 89 例改良 Del Nido 组和 89 例冷血心脏停搏液组。
两组匹配患者在术中除颤的需求(P=0.36)、术后峰值肌钙蛋白 T 水平(0.18)、围术期正性肌力支持(P=0.26)、主动脉内球囊泵需求(P=0.62)以及出院时(P=0.4)和术后第六个月(P=0.37)的左心室射血分数方面无显著差异。Del Nido 组的平均体外循环时间(P=0.005)、体外循环时间(P=0.03)和总手术时间(P=0.03)明显缩短。
在接受心脏手术的成年患者中,温热改良 Del Nido 心脏停搏液可能是冷血心脏停搏液的安全替代方案。